Page last updated: 2024-08-17

bromodeoxyuridine and Ewing Sarcoma

bromodeoxyuridine has been researched along with Ewing Sarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldini, N; Benini, S; Cerisano, V; Lollini, PL; Manara, MC; Mercuri, M; Nanni, P; Picci, P; Scotlandi, K1
Iwai, M; Kosuga, M; Miyahira, Y; Ohta, S; Okabe, H; Shimada, M; Sugiura, Y; Suzuki, A; Suzuki, S; Taga, T1

Other Studies

2 other study(ies) available for bromodeoxyuridine and Ewing Sarcoma

ArticleYear
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:6

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Dose-Response Relationship, Drug; Doxorubicin; Humans; Receptor, IGF Type 1; Sarcoma, Ewing; Suramin; Tumor Cells, Cultured; Vincristine

2001
Neuronal differentiation of Ewing's sarcoma induced by cholera toxin B and bromodeoxyuridine--establishment of Ewing's sarcoma cell line and histochemical study.
    Acta paediatrica Japonica : Overseas edition, 1991, Volume: 33, Issue:4

    Topics: Antigens, Differentiation; Bromodeoxyuridine; Cell Differentiation; Child; Cholera Toxin; Humans; Intermediate Filaments; Male; Neurons; S100 Proteins; Sarcoma, Ewing; Tumor Cells, Cultured

1991